Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$179.3 million.

  • Abivax's Net Income towards Common Stockholders fell 19559.75% to -$179.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$331.3 million, marking a year-over-year decrease of 12236.01%. This contributed to the annual value of -$188.3 million for FY2024, which is 1784.49% down from last year.
  • Abivax's Net Income towards Common Stockholders amounted to -$179.3 million in Q3 2025, which was down 19559.75% from -$54.8 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Net Income towards Common Stockholders ranged from a high of -$41.8 million in Q2 2024 and a low of -$179.3 million during Q3 2025